Oncology has traditionally grouped malignancies by their organ of origin, treating "colorectal cancer," "gastric cancer," or "osteosarcoma" as monolithic disease categories. However, human organs are not uniform blocks of tissue. They are complex, spatially partitioned structures with varied embryological lineages, distinct microenvironments, and unique mechanical constraints.
A growing body of research demonstrates that a tumor's precise anatomical sub-localization within an organ fundamentally alters its molecular wiring, surgical feasibility, and clinical trajectory. This phenomenon—anatomical tumor heterogeneity—shifts our understanding from what a tumor is histologically to where it resides spatially.
The Molecular and Microenvironmental Wiring of Space
Why does a few centimeters of anatomical distance change a tumor's fundamental behavior? The answer lies in the distinct developmental origins and local microenvironments of different organ zones.
In colorectal cancer, for instance, right-sided (proximal) and left-sided (distal) tumors arise from entirely different embryonic segments: the midgut and the hindgut, respectively. Because they develop from different embryological baselines, they maintain distinct molecular networks throughout oncogenesis. Nishihara et al. mapped these differences in Biomarker correlation network in colorectal carcinoma by tumor anatomic location, demonstrating that proximal tumors feature a significantly denser, more interconnected web of molecular interactions. In these right-sided sites, Microsatellite Instability (MSI) and BRAF mutations act as central hubs driving the disease, whereas the same markers remain peripheral in distal tumors. This spatial partitioning is further supported by Song et al. in Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases, who found that right-sided tumors exhibit heightened genetic instability and clinical aggressiveness compared to left-sided ones.
[Embryonic Midgut] ---> Right-Sided Colon ---> Dense Molecular Networks (MSI, BRAF Hubs)
[Embryonic Hindgut] --> Left-Sided Colon ----> Distinct, Less Interconnected Pathways
This spatial divergence extends beyond human genetics to the local microbiome and metabolome. In gastric oncology, Yang et al. revealed in Microbiota and metabolites alterations in proximal and distal gastric cancer patients that proximal and distal stomach tumors harbor entirely unique microbial and metabolic "fingerprints." These localized microenvironments alter baseline biological signaling, explaining why treating an organ as a uniform entity often masks critical site-specific therapeutic vulnerabilities.
Structural and Mechanical Constraints on Intervention
Anatomy does not just dictate how a tumor grows; it dictates what a clinician can physically achieve. The local architecture surrounding a tumor—such as cortical bone thickness, vascular proximity, or depth within an airway—imposes strict boundaries on surgical and radiological success.
Consider primary bone malignancies. Yao et al. investigated this in Comparison of clinical features, management and outcomes of osteosarcoma located in proximal fibula and proximal tibia: a propensity score matching analysis. Although the proximal fibula and proximal tibia are adjacent bones in the lower leg, osteosarcomas in the fibula carry a significantly higher risk of amputation and worse event-free survival. The root cause is purely structural: the fibula's thin bone cortex and extreme proximity to major posterior tibial blood vessels make limb-salvaging resections exceptionally difficult, facilitating rapid soft-tissue invasion and forcing more aggressive surgical interventions.
Proximal Tibia ---> Thick Cortex, Distant Vessels ---> Higher Limb-Salvage Success
Proximal Fibula ---> Thin Cortex, Close Vessels ---> High Soft-Tissue Invasion & Amputation Risk
Similarly, local anatomy alters the safety and efficacy profiles of radiation and thermal therapies. In lung oncology, Li et al. noted in Dosimetric comparison of CT-guided iodine-125 seed sterectactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC that radiation safety profiles shift dramatically depending on whether a tumor is peripheral or central (located near major airways or the mediastinum).
In the biliary system, Sun showed in Radiofrequency Ablation Combined with Stent Placement versus Stent Placement Alone for Malignant Biliary Obstruction: A Systematic Review and Meta-analysis that the survival benefits of thermal ablation are highly sensitive to the tumor's exact location along the biliary tree. Upper-tract (hilar) obstructions respond more favorably to local ablation than lower-tract (distal) obstructions due to differences in procedural access and local tissue dynamics, proving that a treatment's efficacy is often bounded by its anatomical coordinates.
Site-Specific Prognosis and Therapeutic Stratification
Because anatomical location governs both molecular wiring and structural accessibility, it serves as a dominant determinant of patient survival and treatment response.
This reality is increasingly reflected in modern clinical guidelines. For instance, the authors of Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi Method emphasize that the primary tumor's location dictates the choice of biologic therapy in metastatic disease. Anti-EGFR therapies show high efficacy in left-sided RAS wild-type tumors, whereas Bevacizumab is the preferred choice for right-sided tumors.
When tumors metastasize, the location of the primary site continues to cast a long shadow over survival trajectories. Cheng demonstrated in Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases that patients whose primary tumor originated in the transverse colon experience significantly worse cancer-specific survival than those with primaries in other colon segments, even when presenting with identical synchronous lung metastases.
Furthermore, tumors located in central or axial skeletal structures face worse odds of local control. Hazewinkel et al. utilized a multistate model in Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial to show that osteosarcomas residing in the axial skeleton (such as the spine or pelvis) carry a vastly higher risk of local recurrence and post-recurrence mortality compared to extremity tumors.
Even within soft tissues, the depth and lateralization of tumor spread—such as upper versus lower neck nodal involvement in oral squamous cell carcinoma, as detailed by Saito et al. in Clinical and statistical investigation on the regional lymph node metastasis of oral squamous cell carcinoma (Japanese 1979)—fundamentally dictate regional control and long-term survival.
Calibrating Diagnostics to Regional Heterogeneity
If tumor behavior varies by zone, diagnostic frameworks must adapt accordingly. Applying uniform diagnostic thresholds across an entire organ can lead to significant clinical errors.
Prostate cancer diagnostics offer a clear example of this requirement. Wen et al. demonstrated in PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone that combining MRI-based PI-RADS scores with Prostate-Specific Antigen Density (PSAD) significantly improves diagnostic performance in the prostate's peripheral zone. However, in the transition zone, the PI-RADS score alone is highly accurate, and adding PSAD offers no statistical benefit. This discrepancy arises because tissue characteristics and baseline cancer prevalence vary fundamentally across these internal anatomical zones.
Peripheral Zone ---> PI-RADS + PSAD Required ---> Optimizes Diagnostic Accuracy
Transition Zone ---> PI-RADS Alone Sufficient ---> PSAD Adds No Statistical Benefit
Similarly, when evaluating potential metastases, the anatomical context of the lesion changes its statistical probability of being malignant. Phelps et al. showed in Predicting Outcomes of Indeterminate Bone Lesions on18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer that indeterminate bone lesions found in the spine and pelvis carry a significantly higher risk of true malignancy than those found in the ribs, which frequently turn out to be benign results of minor trauma or localized inflammation.
By moving away from broad organ-level classifications and focusing on the precise anatomical coordinates of a tumor, modern oncology can build more accurate prognostic models, design safer interventions, and deliver truly personalized therapies.
Key Foundational Work
Clinical and statistical investigation on the regional lymph node metastasis of oral squamous cell carcinoma (1979) — contributed 2 concept elements to this direction.